Minghui Zhang

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

PET/CT Radiomics-based assessment of tumor heterogeneity for predicting immunotherapy outcomes in advanced lung squamous cell carcinoma: a retrospective prognostic modeling study.

PET/CT Radiomics-based assessment of tumor heterogeneity for predicting immunotherapy outcomes in advanced lung squamous cell carcinoma: a retrospective prognostic modeling study.

Journal: BMC cancer

Published: April 25, 2026

Immune biomarker landscape and fusion partner-phenotype associations in thoracic and head-and-neck NUT carcinoma.

Immune biomarker landscape and fusion partner-phenotype associations in thoracic and head-and-neck NUT carcinoma.

Journal: Frontiers in immunology

Published: March 19, 2026

Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab-Based Treatment: A Case Report.

Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab-Based Treatment: A Case Report.

Journal: The Laryngoscope

Published: February 12, 2026

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer.

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: January 26, 2026

Graph convolutional network-derived pathomics and clinical integration for predicting chemoimmunotherapy response in advanced lung squamous cell carcinoma: a multicenter study.

Graph convolutional network-derived pathomics and clinical integration for predicting chemoimmunotherapy response in advanced lung squamous cell carcinoma: a multicenter study.

Journal: Journal of translational medicine

Published: November 17, 2025

A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors.

A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors.

Journal: Recent patents on anti-cancer drug discovery

Published: October 12, 2025

Tumor immune organoids in immunotherapy resistance and drug screening.

Tumor immune organoids in immunotherapy resistance and drug screening.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: September 04, 2025

A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter study.

A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 26, 2025

A nationwide survey of awareness and understanding of NUT carcinoma among clinicians in China.

A nationwide survey of awareness and understanding of NUT carcinoma among clinicians in China.

Journal: BMC health services research

Published: July 23, 2025

Multimodal Positron Emission Tomography/Computed Tomography Radiomics Combined with a Clinical Model for Preoperative Prediction of Invasive Pulmonary Adenocarcinoma in Ground-Glass Nodules.

Multimodal Positron Emission Tomography/Computed Tomography Radiomics Combined with a Clinical Model for Preoperative Prediction of Invasive Pulmonary Adenocarcinoma in Ground-Glass Nodules.

Journal: Academic radiology

Published: June 23, 2025

Erratum to 'Multimodal Positron Emission Tomography/Computed Tomography Radiomics Combined with a Clinical Model for Preoperative Prediction of Invasive Pulmonary Adenocarcinoma in Ground-Glass Nodules' [Acad Radiol 2025; 32:6929-6942].

Erratum to 'Multimodal Positron Emission Tomography/Computed Tomography Radiomics Combined with a Clinical Model for Preoperative Prediction of Invasive Pulmonary Adenocarcinoma in Ground-Glass Nodules' [Acad Radiol 2025; 32:6929-6942].

Journal: Academic radiology

Published: June 23, 2025

Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk.

Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk.

Journal: Cell reports. Medicine

Published: May 28, 2025

Showing 1-12 of 30

Last Updated: 09/26/2026